441 related articles for article (PubMed ID: 20873400)
1. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
Hull CM; Brunton S
Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of combination acyclovir 5% and hydrocortisone 1% cream in adolescents with recurrent herpes simplex labialis.
Strand A; Böttiger D; Gever LN; Wheeler W
Pediatr Dermatol; 2012; 29(1):105-10. PubMed ID: 22004219
[TBL] [Abstract][Full Text] [Related]
3. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
Nguyen HP; Stiegel KR; Downing C; Stiegel KR
Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
[TBL] [Abstract][Full Text] [Related]
4. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial.
Hull CM; Harmenberg J; Arlander E; Aoki F; Bring J; Darpö B; Levin MJ; Tyring S; Spruance SL;
J Am Acad Dermatol; 2011 Apr; 64(4):696.e1-11. PubMed ID: 20851499
[TBL] [Abstract][Full Text] [Related]
5. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.
Evans TG; Bernstein DI; Raborn GW; Harmenberg J; Kowalski J; Spruance SL
Antimicrob Agents Chemother; 2002 Jun; 46(6):1870-4. PubMed ID: 12019102
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Topical 5% Acyclovir-1% Hydrocortisone Cream (ME-609) for Treatment of Herpes Labialis: a systematic review.
Rosa MI; Souza SL; Farias BF; Pires PD; Dondossola ER; dos Reis ME
An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1415-20. PubMed ID: 26247156
[TBL] [Abstract][Full Text] [Related]
8. Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.
Hull CM; Levin MJ; Tyring SK; Spruance SL
Antimicrob Agents Chemother; 2014; 58(3):1273-8. PubMed ID: 24342632
[TBL] [Abstract][Full Text] [Related]
9. Interventions for prevention of herpes simplex labialis (cold sores on the lips).
Chi CC; Wang SH; Delamere FM; Wojnarowska F; Peters MC; Kanjirath PP
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010095. PubMed ID: 26252373
[TBL] [Abstract][Full Text] [Related]
10. Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid.
Prescrire Int; 2011 Sep; 20(119):205-7. PubMed ID: 21954513
[TBL] [Abstract][Full Text] [Related]
11. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials.
Raborn GW; Martel AY; Lassonde M; Lewis MA; Boon R; Spruance SL;
J Am Dent Assoc; 2002 Mar; 133(3):303-9. PubMed ID: 11934185
[TBL] [Abstract][Full Text] [Related]
12. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
[TBL] [Abstract][Full Text] [Related]
13. Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial.
Zschocke I; Reich C; Zielke A; Reitmeier N; Reich K
J Dermatolog Treat; 2008; 19(3):176-81. PubMed ID: 18569274
[TBL] [Abstract][Full Text] [Related]
14. Herpes Labialis: An Update.
Leung AKC; Barankin B
Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):107-113. PubMed ID: 28971780
[TBL] [Abstract][Full Text] [Related]
15. Recurrent herpes simplex labialis: selected therapeutic options.
Raborn GW; Grace MG
J Can Dent Assoc; 2003 Sep; 69(8):498-503. PubMed ID: 12954137
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis.
Karlsmark T; Goodman JJ; Drouault Y; Lufrano L; Pledger GW;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1184-92. PubMed ID: 18462303
[TBL] [Abstract][Full Text] [Related]
17. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
[TBL] [Abstract][Full Text] [Related]
19. Topical acyclovir in the treatment of recurrent herpes simplex virus infections.
Kinghorn GR
Scand J Infect Dis Suppl; 1985; 47():58-62. PubMed ID: 3912972
[TBL] [Abstract][Full Text] [Related]
20. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection.
McKeough MB; Spruance SL
Arch Dermatol; 2001 Sep; 137(9):1153-8. PubMed ID: 11559210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]